227 related articles for article (PubMed ID: 31652745)
1. Influence of Immunogenetic Biomarkers in the Clinical Outcome of HTLV-1 Infected Persons.
Vallinoto ACR; Cayres-Vallinoto I; Freitas Queiroz MA; Ishak MOG; Ishak R
Viruses; 2019 Oct; 11(11):. PubMed ID: 31652745
[TBL] [Abstract][Full Text] [Related]
2. Immunological signature of the different clinical stages of the HTLV-1 infection: establishing serum biomarkers for HTLV-1-associated disease morbidity.
Starling AL; Coelho-Dos-Reis JG; Peruhype-Magalhães V; Pascoal-Xavier MA; Gonçalves DU; Béla SR; Lambertucci JR; Labanca L; Souza Pereira SR; Teixeira-Carvalho A; Ribas JG; Trindade BC; Faccioli LH; Carneiro-Proietti AB; Martins-Filho OA
Biomarkers; 2015; 20(6-7):502-12. PubMed ID: 26474234
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of HTLV-1 infection and progression biomarkers: An overview.
Brites C; Grassi MF; Quaresma JAS; Ishak R; Vallinoto ACR
Braz J Infect Dis; 2021; 25(3):101594. PubMed ID: 34256025
[TBL] [Abstract][Full Text] [Related]
4. HTLV-1-host interactions on the development of adult T cell leukemia/lymphoma: virus and host gene expressions.
Tarokhian H; Rahimi H; Mosavat A; Shirdel A; Rafatpanah H; Akbarin MM; Bari A; Ramezani S; Rezaee SA
BMC Cancer; 2018 Dec; 18(1):1287. PubMed ID: 30577817
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of HTLV-1 HBZ and proviral load, together with host IFN λ3, in pathogenesis of HAM/TSP.
Mozhgani SH; Jaberi N; Rezaee SA; Bustani R; Jazayeri SM; Akbarin MM; Milani S; Tarokhian H; Norouzi M
J Med Virol; 2017 Jun; 89(6):1102-1107. PubMed ID: 27787900
[TBL] [Abstract][Full Text] [Related]
6. HTLV-1, Immune Response and Autoimmunity.
Quaresma JA; Yoshikawa GT; Koyama RV; Dias GA; Fujihara S; Fuzii HT
Viruses; 2015 Dec; 8(1):. PubMed ID: 26712781
[TBL] [Abstract][Full Text] [Related]
7. HTLV-1 infects human mesenchymal stromal cell in vitro and modifies their phenotypic characteristics.
Rodrigues ES; de Macedo MD; Pinto MT; Orellana MD; Rocha Junior MC; de Magalhães DA; Tanaka Y; Takayanagui OM; Covas DT; Kashima S
Virology; 2014 Jan; 449():190-9. PubMed ID: 24418552
[TBL] [Abstract][Full Text] [Related]
8. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
[TBL] [Abstract][Full Text] [Related]
9. Experimental acute adult T cell leukemia-lymphoma is associated with thymic atrophy in human T cell leukemia virus type I infection.
Simpson RM; Zhao TM; Hubbard BS; Sawasdikosol S; Kindt TJ
Lab Invest; 1996 Mar; 74(3):696-710. PubMed ID: 8600320
[TBL] [Abstract][Full Text] [Related]
10. [Human retrovirus HTLV-1: descriptive and molecular epidemiology, origin, evolution, diagnosis and associated diseases].
Gessain A
Bull Soc Pathol Exot; 2011 Aug; 104(3):167-80. PubMed ID: 21796326
[TBL] [Abstract][Full Text] [Related]
11. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
12. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.
de Souza JG; da Fonseca FG; Martins ML; Martins CP; de Carvalho LD; Coelho-dos-Reis JG; Carneiro-Proietti AB; Martins-Filho OA; Barbosa-Stancioli EF;
J Clin Virol; 2011 Jan; 50(1):13-8. PubMed ID: 20951636
[TBL] [Abstract][Full Text] [Related]
13. p30 protein: a critical regulator of HTLV-1 viral latency and host immunity.
Moles R; Sarkis S; Galli V; Omsland M; Purcell DFJ; Yurick D; Khoury G; Pise-Masison CA; Franchini G
Retrovirology; 2019 Dec; 16(1):42. PubMed ID: 31852501
[TBL] [Abstract][Full Text] [Related]
14. The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis.
Tarokhian H; Taghadosi M; Rafatpanah H; Rajaei T; Azarpazhooh MR; Valizadeh N; Rezaee SAR
Virus Res; 2017 Jan; 228():1-6. PubMed ID: 27845163
[TBL] [Abstract][Full Text] [Related]
15. HLA-G 3'-untranslated region polymorphisms are associated with HTLV-1 infection, proviral load and HTLV-associated myelopathy/tropical spastic paraparesis development.
Cilião Alves DC; Haddad R; Rocha-Júnior MC; de Deus Wagatsuma VM; Martelli-Palomino G; Marques AA; Takayanagui OM; Covas DT; Kashima S; Donadi EA
J Gen Virol; 2016 Oct; 97(10):2742-2752. PubMed ID: 27449667
[TBL] [Abstract][Full Text] [Related]
16. Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
Baratella M; Forlani G; Raval GU; Tedeschi A; Gout O; Gessain A; Tosi G; Accolla RS
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005285. PubMed ID: 28095504
[TBL] [Abstract][Full Text] [Related]
17. Genetic Markers of the Host in Persons Living with HTLV-1, HIV and HCV Infections.
Assone T; Paiva A; Fonseca LA; Casseb J
Viruses; 2016 Feb; 8(2):. PubMed ID: 26848682
[TBL] [Abstract][Full Text] [Related]
18. Human T-lymphotropic virus 1 (HTLV-1) infection--dermatological implications.
Amano M; Setoyama M; Grant A; Kerdel FA
Int J Dermatol; 2011 Aug; 50(8):915-20. PubMed ID: 21781059
[TBL] [Abstract][Full Text] [Related]
19. Human T cell lymphotropic virus (HTLV-1): when to suspect infection?
Romanelli LC; Caramelli P; Proietti AB
Rev Assoc Med Bras (1992); 2010; 56(3):340-7. PubMed ID: 20676544
[TBL] [Abstract][Full Text] [Related]
20. Modes of Human T Cell Leukemia Virus Type 1 Transmission, Replication and Persistence.
Carpentier A; Barez PY; Hamaidia M; Gazon H; de Brogniez A; Perike S; Gillet N; Willems L
Viruses; 2015 Jul; 7(7):3603-24. PubMed ID: 26198240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
